📰 Frederick Beddingfield News
Frederick Beddingfield News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Frederick Beddingfield. Real-time updates on events, politics, business and more.
January 6, 2023
Kira to Present at the 41st Annual J.P. Morgan Healthcare Conference - read this article along with other careers information, tips and advice on BioSpace
December 21, 2022
Kira Pharmaceuticals has received clearances in China and Australia to commence Phase II trials of KP104 for IgAN and C3G.
December 20, 2022
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases,...
December 20, 2022
CAMBRIDGE, Mass., Dec. 20, 2022 /PRNewswire/ — Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases,...
November 3, 2022
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today...
October 13, 2022
CAMBRIDGE, Mass., Oct. 13, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therap...
August 27, 2022
Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference - read this article along with other careers information, tips and advice on BioSpace
August 26, 2022
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, will...
August 10, 2022
The FDA has granted Orphan Drug designation to KP104 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
August 2, 2022
CAMBRIDGE, Mass. and SUZHOU, China, Aug. 2, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced the appointment of Angela (Hui) Yan as President of China and Asia Development and Operations. In this role, Ms. Yan will lead Kira's China division, overseeing clinical development execution and strategy as well as operational excellence for China and Asia. &quo...